Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-20-000071

Chief Financial Officer gave up 1,707 shares (to pay taxes)

  • Chief Financial Officer acquired 5,753 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Biller Jonathan · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2020-12-03 Exercise or conversion : show line 1 in the form +5,753 11,747 D
2020-12-03 Shares withheld for taxes : show line 2 in the form −1,707 $45.87 $78,300 10,040 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-12-03 Exercise or conversion : show line 3 in the form Restricted stock units −5,753 11,506 D
Loading xslF345X03/wf-form4_160738329299398.xml…